Clinical Trial Update: A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma [Phase 2, Phase 3]

View source ↗

Summary

A multi-regimen Phase 2/3 clinical trial in newly diagnosed and recurrent glioblastoma is currently recruiting. The study is sponsored by the Global Coalition f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Global Coalition for Adaptive Research | Conditions: Glioblastoma | Phase 2, Phase 3 | Status: RECRUITING